Is HALP a new marker for preeclampsia? Retrospective evaluation of the diagnostic accuracy of the HALP index compared to other inflammatory and nutritional markers
Ege Tıp Dergisi · 10.06.2026 · 65 (2) · 268-274
DOI: 10.19161/etd.1827265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ege Tıp Dergisi, online erschienen am 10.06.2026. Verfasst von İsmail Bağlar und 7 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Gefördert von: non.
Abstract (Originalsprache)
Aim
Preeclampsia (PE) poses a significant threat to maternal and fetal health. The Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) index has emerged as a novel biomarker providing information on inflammation and nutritional status. The aim of this study is to evaluate the performance of the HALP index in diagnosing PE, comparing it with other commonly used inflammatory and nutritional markers.Materials and Methods: In this retrospective case-control study, 173 women who gave birth at a tertiary hospital between 2020 and 2025 and were diagnosed with PE were examined, along with a control group of 185 healthy pregnant women. The HALP score, Prognostic Nutritional Index (PNI), Neutrophil-Lymphocyte Ratio (NLR), Systemic Immune-Inflammation Index (SII), and serum uric acid/creatinine ratio (sUA/sCr) were calculated for the participants. Diagnostic performance was evaluated using ROC curves and comparing AUC (Area Under the Curve) values.
Results
In women in the PE group, the HALP score (2.5 vs. 3.8) and PNI value (34.5 vs. 41.0) were significantly lower (p < 0.001 for both). In contrast, NLR, SII, serum uric acid level, and sUA/sCr ratio were significantly higher in the PE group (all p < 0.001). According to ROC analysis, uric acid had the highest diagnostic accuracy with an AUC value of 0.805 (95% CI: 0.758-0.852). The HALP score showed a significant but relatively low diagnostic accuracy (AUC: 0.625, 95% CI: 0.566-0.684),(p < 0.01 for all).
Conclusions
Although the HALP score is significantly lower in women with preeclampsia, its diagnostic performance during diagnosis lags behind established biomarkers such as uric acid, sUA/sCr, PNI, and SII.
Förderung
- non
Zitieren
APA
Bağlar, İ., Şanlıkan, F., Keles, E., Çivi, B. Y., Gökulu, Ş. G., Aşci, H., Ağır, D., & Sezgin, B. (2026). Is HALP a new marker for preeclampsia? Retrospective evaluation of the diagnostic accuracy of the HALP index compared to other inflammatory and nutritional markers. Ege Tıp Dergisi, 65(2), 268-274. https://doi.org/10.19161/etd.1827265
Vancouver
Bağlar İ, Şanlıkan F, Keles E, Çivi BY, Gökulu ŞG, Aşci H, et al. Is HALP a new marker for preeclampsia? Retrospective evaluation of the diagnostic accuracy of the HALP index compared to other inflammatory and nutritional markers. Ege Tıp Dergisi. 2026;65(2):268-274. doi:10.19161/etd.1827265
BibTeX
@article{Balar2026,
author = {Bağlar, İsmail and Şanlıkan, Fatih and Keles, Esra and Çivi, Buket Yiğit and Gökulu, Şevki Göksun and Aşci, Hilal and Ağır, Dilanur and Sezgin, Burak},
title = {Is HALP a new marker for preeclampsia? Retrospective evaluation of the diagnostic accuracy of the HALP index compared to other inflammatory and nutritional markers},
journal = {Ege Tıp Dergisi},
year = {2026},
volume = {65},
number = {2},
pages = {268--274},
doi = {10.19161/etd.1827265}
}
EUVIMED